Histology and Cytology Market By Type of Examination (Cytology and Histology) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The histology and cytology market is expected to grow at a compound annual growth rate (CAGR) of 13.6% from 2018 to 2026, from US$ 8,928.1 million in 2017 to US$ 27,949.9 million by 2026. As per the research citations provided by the World Health Organization (WHO), the global burden of cancer is approximately 18.1 million new cases and 9.6 million deaths in 2018.

The major factors responsible for the occurrence of chronic disease are increased consumption of tobacco, alcohol, and junk food, a sedentary lifestyle, and stress. Researchers are of the view that, in the era of modern technology, the utilization of sophisticated technology pertaining to histology and cytology examinations will help in promoting early diagnosis and curtailing morbidity associated with chronic ailments. Rising public health awareness will support the growth of the histology and cytology markets from 2018 to 2026.

Market Synopsis

Increasing demand for cell screening and inherent features such as low cost, high sensitivity, and adequate specificity drive the cytology examination market's growth.

Cytology examinations dominate the type of examination segment in the histology and cytology market. Increased demand for cell screening in breast and cervical cancer patients is one of the growth factors driving the cytology examination market. Inherent features such as low cost, high sensitivity, and adequate specificity associated with the cytology examination procedure further fortify its market growth.

Histology examination procedures will be growing at a rapid pace on account of technological advancement in tissue diagnostic kits and strategic collaboration among major players for the further development and commercialization of histology examination procedures in the diagnosis of chronic ailments.

In North America, market growth is being driven by an increase in cancer diagnoses and increased public health awareness.

North America currently holds 35% of the market and is the leading regional market for histology and cytology. The major factors controlling its market growth are the significant rise in cancer diagnosis and increasing public health awareness. As per the statistics provided by the Centers for Disease Control and Prevention (CDC) in 2017, the number of adults diagnosed with cancer was 23.2 million, which represents 9.4% of the total population. The existence of key players such as Abbott Laboratories, Inc., Hologic, Inc., Thermo Fisher Scientific, Inc., etc., provides a positive impetus to the histology and cytology market growth in the North American region.

On account of the rising prevalence of cancer and the supportive environment provided by the European Medical Agency (EMA), Europe holds 30% of the market share for histology and cytology diagnostic procedures. Asia Pacific is accountable for 16% of the market share and is keen to register outstanding growth owing to rampant growth in healthcare infrastructure development and the adoption of sophisticated diagnostic technology pertaining to cytology and histology studies.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respectivesegments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by type of examination and by geography.

Biotechnology companies specializing in the histology and cytology market are Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Trivitron Healthcare, Hologic, Inc., Koninklijke Philips N.V., and Life Technologies Corporation.

Key questions are answered in this report.

  • Which biotechnology companies are engaged in the development of histology and cytology examination technology?
  • What is the global prevalence rate of life-threatening chronic ailments?
  • Which strategic collaborations and mergers among major players will promote the histology and cytology market's growth?
  • Which factors are responsible for the manifestation of cancer?
  • Why is the cytology examination procedure more popular in comparison to the histology examination procedure?
  • Why are North America and Europe responsible for the major market share in the regional segment of the histology and cytology market?

Frequently Asked Question:

The market for Histology and Cytology Market is expected to reach USD$ 27,949.9 Mn in 2026.

The Histology and Cytology Market is expected to see significant CAGR growth over the coming years, at 13.6%.

The report is forecasted from 2018 -2026.

The base year of this report is 2017.

Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F. Hoffmann-La Roche Ltd . are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Apr 2019
Category:  Biotechnology
Report ID:   59673
Report Format:   PDF
Pages:   120
Rating:    4.2 (49)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support